05.01.2013 Views

SUNDAY, DECEMBER 4- Late Abstracts 1 - Molecular Biology of the ...

SUNDAY, DECEMBER 4- Late Abstracts 1 - Molecular Biology of the ...

SUNDAY, DECEMBER 4- Late Abstracts 1 - Molecular Biology of the ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>SUNDAY</strong><br />

2035<br />

Inhibition <strong>of</strong> Notch1 signaling by APP intracellular domain.<br />

E-J. Ann 1 , J-H. Yoon 1 , J-S. Ahn 1 , H-S. Park 1 ; 1 Chonnam National University, Gwangju, Korea<br />

The Notch1 receptor is a crucial controller <strong>of</strong> cell fate decisions, and is also a key regulator <strong>of</strong><br />

cell growth and differentiation in a variety <strong>of</strong> contexts. In this study, we have demonstrated that<br />

<strong>the</strong> APP intracellular domain (AICD) attenuates Notch1 signaling by accelerated degradation <strong>of</strong><br />

<strong>the</strong> Notch1 intracellular domain (Notch1-IC) and RBP-Jk, through different degradation<br />

pathways. AICD suppresses Notch1 transcriptional activity by <strong>the</strong> dissociation <strong>of</strong> <strong>the</strong> Notch1-IC–<br />

RBP-Jk complex after processing by gamma-secretase. Notch1-IC is capable <strong>of</strong> forming a<br />

trimeric complex with Fbw7 and AICD, and AICD enhances <strong>the</strong> protein degradation <strong>of</strong> Notch1-<br />

IC through an Fbw7-dependent proteasomal pathway. AICD downregulates <strong>the</strong> levels <strong>of</strong> RBP-<br />

Jk protein through <strong>the</strong> lysosomal pathway. AICD-mediated degradation is involved in <strong>the</strong><br />

preferential degradation <strong>of</strong> non-phosphorylated RBP-Jk. Collectively, our results demonstrate<br />

that AICD functions as a negative regulator in Notch1 signaling through <strong>the</strong> promotion <strong>of</strong><br />

Notch1-IC and RBP-Jk protein degradation.<br />

2036<br />

Isoprenylcysteine methylation is required for growth and endocytosis in Dictyostelium<br />

discoideum.<br />

K. J. McQuade 1 , J. Bollan 1 , K. Bailey 1 , J. Fritz 1 ; 1 Colorado Mesa University, Grand Junction, CO<br />

Many members <strong>of</strong> <strong>the</strong> Ras superfamily <strong>of</strong> small monomeric GTPases and o<strong>the</strong>r membraneassociated<br />

proteins ending in carboxy-terminal –CAAX motifs are proteolytically processed and<br />

reversibly methylated on isoprenylated terminal cysteine residues. Methylation is thought to<br />

regulate localization and activity <strong>of</strong> <strong>the</strong>se proteins. Ras GTPases are <strong>of</strong>ten overactive in cancer<br />

cells and inhibitors <strong>of</strong> isoprenylcysteine methyltransferase are being tested as potential<br />

chemo<strong>the</strong>rapies, but <strong>the</strong> cellular effects <strong>of</strong> <strong>the</strong>se inhibitors are unclear. We are characterizing<br />

<strong>the</strong> effects <strong>of</strong> loss <strong>of</strong> isoprenylcysteine methyltransferase activity in <strong>the</strong> social amoeba,<br />

Dictyostelium discodeum. Amoebae lacking methyltransferase activity grow slowly on bacterial<br />

lawns and do not grow in shaking or adherent axenic culture. Methyltransferase-deficient cells<br />

also migrate slowly towards folate, have reduced rates <strong>of</strong> endocytosis and are sensitive to<br />

osmotic shock. The mechanisms underlying <strong>the</strong>se defects are being investigated.<br />

2037<br />

Understanding <strong>the</strong> cellular function <strong>of</strong> poly(ADP-ribose) and its importance in cancer.<br />

K. Krukenberg 1 , T. Mitchison 2 ; 1 Systems <strong>Biology</strong>, Harvard Medical School, Boston, MA,<br />

2 Systems <strong>Biology</strong>, Harvard Medical School<br />

Poly(ADP-ribose) is a unique but poorly understood post-translational modification. It has been<br />

implicated in multiple cellular processes including DNA damage, cell death, inflammation,<br />

protein stability and cell division. In <strong>the</strong> clinic, inhibition <strong>of</strong> poly(ADP-ribose) formation is showing<br />

promise as a cancer <strong>the</strong>rapeutic. Poly(ADP-ribose) polymerases (PARPs) catalyze <strong>the</strong> addition<br />

<strong>of</strong> ADP-ribose onto acceptor proteins using NAD+ as a substrate. Though <strong>the</strong> importance <strong>of</strong><br />

PARPs and poly(ADP-ribose) is clear, <strong>the</strong>ir biological functions are not well understood. We are<br />

working on developing tools for characterizing <strong>the</strong> function <strong>of</strong> PARPs and poly(ADP-ribose) and<br />

are using <strong>the</strong>se tools to fur<strong>the</strong>r identify and define <strong>the</strong> biological roles <strong>of</strong> <strong>the</strong>se intriguing and<br />

essential molecules. Here we describe an assay for quantifying <strong>the</strong> levels <strong>of</strong> poly(ADP-ribose) in<br />

cells that has increased sensitivity as compared to previous approaches. Using this assay, we<br />

quantified <strong>the</strong> extent to which poly(ADP-ribose) levels vary throughout <strong>the</strong> cell cycle. We have<br />

also found that different cancer cell types have different amounts <strong>of</strong> poly(ADP-ribose) and <strong>the</strong>se

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!